Search
Descriptor English: Nasal Decongestants
Descriptor Spanish: Descongestionantes Nasales
Descriptor descongestionantes nasales
Entry term(s) descongestionante
descongestionantes
descongestivo nasal
vasoconstrictores nasales
Scope note: Fármacos creados para tratar la inflamación de las vías nasales, generalmente debida a una infección (la mayoría de las veces un resfriado común) o a una afección alérgica relacionada, como la rinitis alérgica. La inflamación produce edema de la mucosa que recubre las vías nasales, lo que conlleva la producción excesiva de moco. La clase principal de descongestionantes nasales son los fármacos vasoconstrictores. (PharmAssist, The Family Guide to Health and Medicine, 1993)
Descriptor Portuguese: Descongestionantes Nasais
Descriptor French: Décongestionnant nasal
Entry term(s): Agents, Nasal Vasoconstrictor
Decongestant
Decongestant, Nasal
Decongestants
Decongestants, Nasal
Nasal Decongestant
Nasal Vasoconstrictor Agents
Nasal Vasoconstrictors
Vasoconstrictor Agents, Nasal
Vasoconstrictors, Nasal
Tree number(s): D27.505.954.411.793.610
D27.505.954.796.560
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D014663
Scope note: Drugs designed to treat inflammation of the nasal passages, generally the result of an infection (more often than not the common cold) or an allergy related condition, e.g., hay fever. The inflammation involves swelling of the mucous membrane that lines the nasal passages and results in inordinate mucus production. The primary class of nasal decongestants are vasoconstrictor agents. (From PharmAssist, The Family Guide to Health and Medicine, 1993)
Annotation: Nasal Decongestants - do not use entry term VASOCONSTRICTOR AGENTS, NASAL for the nasal administration of systemic vasoconstrictor agents; use instead the specific vasoconstrictor agent / admin + ADMINISTRATION, INTRANASAL
Allowable Qualifiers: AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Previous Indexing: Sympathomimetics (1966)
Public MeSH Note: 96; was VASOCONSTRICTOR AGENTS, NASAL 1967-95; NASAL DECONGESTANTS was see VASOCONSTRICTOR AGENTS, NASAL 1967-95
History Note: 96; was VASOCONSTRICTOR AGENTS, NASAL 1967-95; NASAL DECONGESTANTS was see VASOCONSTRICTOR AGENTS, NASAL 1967-95
DeCS ID: 15066
Unique ID: D014663
NLM Classification: QV 120
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1967/01/01
Date of Entry: 1999/01/01
Revision Date: 2020/05/27
Nasal Decongestants - Preferred
Concept UI M0022552
Scope note Drugs designed to treat inflammation of the nasal passages, generally the result of an infection (more often than not the common cold) or an allergy related condition, e.g., hay fever. The inflammation involves swelling of the mucous membrane that lines the nasal passages and results in inordinate mucus production. The primary class of nasal decongestants are vasoconstrictor agents. (From PharmAssist, The Family Guide to Health and Medicine, 1993)
Preferred term Nasal Decongestants
Entry term(s) Decongestant, Nasal
Decongestants, Nasal
Nasal Decongestant
Decongestants - Broader
Concept UI M0022554
Preferred term Decongestants
Entry term(s) Decongestant
Vasoconstrictor Agents, Nasal - Narrower
Concept UI M0022555
Preferred term Vasoconstrictor Agents, Nasal
Entry term(s) Agents, Nasal Vasoconstrictor
Nasal Vasoconstrictor Agents
Nasal Vasoconstrictors
Vasoconstrictors, Nasal



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey